Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC

Details for Australian Patent Application No. 2009285547 (hide)

Owner Taiga Biotechnologies, Inc.

Inventors Refaeli, Yosef; Turner, Brian Curtis

Agent Spruson & Ferguson

Pub. Number AU-B-2009285547

PCT Pub. Number WO2010/025421

Priority 61/092,708 28.08.08 US

Filing date 28 August 2009

Wipo publication date 4 March 2010

Acceptance publication date 31 May 2012

International Classifications

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/025421 Priority application(s): WO2010/025421

31 May 2012 Application Accepted

  Published as AU-B-2009285547

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009285548-Systems for achieving and assisting in improved nutrition based healthfulness

2009285540-Diagnostics and treatments for VEGFindependent tumors